AZN buys US/Canada respiratory business from ACT for $600M in cash: http://finance.yahoo.com/news/astrazeneca-buy-actavis-lung-drugs-071908968.html It’s rare to see a roll-up company such as ACT selling a business; perhaps this is a preemptive move to spearhead yet another acquisition.